Ringpu Bio-Technology secures two new veterinary drug approvals
Ringpu Bio-Technology and its subsidiaries announced the acquisition of two new veterinary drug registration certificates from the Ministry of Agriculture and Rural Affairs.
The first approval is for "Avian Adenovirus (Group I, Type 4) Egg Yolk Antibody," classified as a Class III new veterinary drug. This antibody is designed to rapidly neutralize FAdV-4 and alleviate liver necrosis and pericardial effusion in chickens.
The second approval is for "Penicillin V Potassium Soluble Powder," categorized as a Class V new veterinary drug, effective against Clostridium perfringens-induced avian necrotic enteritis.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Tianjin Ringpu Bio-Technology publishes news
Free account required • Unsubscribe anytime